Perkins Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $964K | Sell |
7,500
-250
| -3% | -$29.3K | 0.72% | 35 |
|
|
2026
Q1 | $932K | Sell |
7,750
-1,000
| -11% | -$115K | 0.87% | 32 |
|
|
2025
Q4 | $921K | Hold |
8,750
| – | – | 0.73% | 42 |
|
|
2025
Q3 | $734K | Hold |
8,750
| – | – | 0.65% | 45 |
|
|
2025
Q2 | $693K | Sell |
8,750
-1,750
| -17% | -$139K | 0.7% | 41 |
|
|
2025
Q1 | $942K | Hold |
10,500
| – | – | 0.99% | 32 |
|
|
2024
Q4 | $1.04M | Sell |
10,500
-250
| -2% | -$25.8K | 0.93% | 38 |
|
|
2024
Q3 | $1.22M | Sell |
10,750
-1,175
| -10% | -$140K | 1.14% | 29 |
|
|
2024
Q2 | $1.48M | Sell |
11,925
-300
| -2% | -$38.6K | 1.39% | 21 |
|
|
2024
Q1 | $1.61M | Hold |
12,225
| – | – | 1.35% | 23 |
|
|
2023
Q4 | $1.33M | Buy |
12,225
+400
| +3% | +$41.5K | 1.14% | 28 |
|
|
2023
Q3 | $1.22M | Hold |
11,825
| – | – | 1.21% | 28 |
|
|
2023
Q2 | $1.36M | Hold |
11,825
| – | – | 1.19% | 33 |
|
|
2023
Q1 | $1.26M | Sell |
11,825
-100
| -0.8% | -$10.8K | 1.19% | 32 |
|
|
2022
Q4 | $1.32M | Hold |
11,925
| – | – | 1.4% | 25 |
|
|
2022
Q3 | $1.03M | Sell |
11,925
-100
| -0.8% | -$8.93K | 1.15% | 30 |
|
|
2022
Q2 | $1.1M | Hold |
12,025
| – | – | 1.13% | 34 |
|
|
2022
Q1 | $987K | Hold |
12,025
| – | – | 0.81% | 46 |
|
|
2021
Q4 | $922K | Sell |
12,025
-250
| -2% | -$19.9K | 0.62% | 56 |
|
|
2021
Q3 | $922K | Hold |
12,275
| – | – | 0.57% | 53 |
|
|
2021
Q2 | $955K | Sell |
12,275
-589
| -5% | -$43.8K | 0.54% | 55 |
|
|
2021
Q1 | $946K | Hold |
12,864
| – | – | 0.55% | 56 |
|
|
2020
Q4 | $1M | Sell |
12,864
-524
| -4% | -$40.1K | 0.66% | 46 |
|
|
2020
Q3 | $1.06M | Buy |
+13,388
| New | +$1.05M | 0.97% | 35 |
|
|
2020
Q1 | $986K | Buy |
13,430
+995
| +8% | +$78.2K | 1.19% | 30 |
|
|
2019
Q4 | $1.08M | Buy |
12,435
+131
| +1% | +$10.8K | 0.97% | 36 |
|
|
2019
Q3 | $988K | Buy |
12,304
+2,620
| +27% | +$210K | 0.85% | 46 |
|
|
2019
Q2 | $775K | Sell |
9,684
-62
| -0.6% | -$4.75K | 0.54% | 54 |
|
|
2019
Q1 | $773K | Buy |
9,746
+1,572
| +19% | +$118K | 0.51% | 61 |
|
|
2018
Q4 | $596K | Sell |
8,174
-210
| -3% | -$14.8K | 0.46% | 66 |
|
|
2018
Q3 | $568K | Sell |
8,384
-419
| -5% | -$26.7K | 0.34% | 83 |
|
|
2018
Q2 | $510K | Sell |
8,803
-262
| -3% | -$14.8K | 0.37% | 78 |
|
|
2018
Q1 | $471K | Buy |
9,065
+2,987
| +49% | +$161K | 0.42% | 68 |
|
|
2017
Q4 | $326K | Sell |
6,078
-3,564
| -37% | -$198K | 0.31% | 81 |
|
|
2017
Q3 | $589K | Hold |
9,642
| – | – | 0.62% | 50 |
|
|
2017
Q2 | $590K | Buy |
9,642
+2,568
| +36% | +$156K | 0.65% | 50 |
|
|
2017
Q1 | $429K | Buy |
7,074
+2,096
| +42% | +$127K | 0.44% | 72 |
|
|
2016
Q4 | $280K | Buy |
+4,978
| New | +$291K | 0.31% | 80 |
|
Other funds holding MRK
ECSS
Perkins Capital Management's MRK Position: Q2 2026 in Review
Perkins Capital Management reduced its Merck (MRK) stake by 3.2% in Q2 2026, selling an estimated $29.3K and leaving 7,500 shares worth $964K. The position accounts for 0.72% of the portfolio, ranked #35.
Perkins Capital Management first reported a position in MRK in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.61M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Perkins Capital Management held 7,500 shares of Merck worth $964K as of Q2 2026.
- Perkins Capital Management sold 250 Merck shares in Q2 2026, an estimated $29.3K.
- Merck made up 0.72% of Perkins Capital Management's portfolio in Q2 2026, its #35 holding.
- Perkins Capital Management first reported a position in Merck in Q4 2016 and has held it in 38 quarters since.
- Perkins Capital Management's Merck position peaked at $1.61M in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.